4870 related articles for article (PubMed ID: 2532801)
1. [Immune status of patients with malignant melanoma during combined therapy including local ultra-high frequency hyperthermia].
Risina DIa; Zhakov IG; Fradkin SZ; Zhabrid EA
Vopr Onkol; 1989; 35(12):1437-40. PubMed ID: 2532801
[TBL] [Abstract][Full Text] [Related]
2. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia].
Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK
Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of hyperthermia and radiation for superficial tumors.
Jones EL; Oleson JR; Prosnitz LR; Samulski TV; Vujaskovic Z; Yu D; Sanders LL; Dewhirst MW
J Clin Oncol; 2005 May; 23(13):3079-85. PubMed ID: 15860867
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral lymphocyte populations in patients treated with pelvic and mediastinal radiotherapy].
Jirillo A; Balli M; Disperati A; Capuzzo E; Chiavolini P; Lonardi F
Radiol Med; 1989 Nov; 78(5):448-51. PubMed ID: 2532757
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotype of lymphocytes of patients with malignant melanoma and its dynamics during immunotherapy with interleukin-2].
Kadagidze ZG; Iavorskiĭ VV; Baryshnikov AIu; Solov'eva EA; Savel'eva EV; Cheremushkin EA; Korotkova OV
Vopr Onkol; 1991; 37(5):544-9. PubMed ID: 1767507
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
9. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
10. [Results and prospects for the clinical use of hyperthermia in oncology].
Savchenko NE; Zhakov IG; Fradkin SZ; Zhavrid ZA
Med Radiol (Mosk); 1987 Jan; 32(1):19-24. PubMed ID: 3807694
[TBL] [Abstract][Full Text] [Related]
11. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte subpopulations in patients with skin basalioma of the trunk].
Röcken M; Link C; Weber T; Nerl C
Z Hautkr; 1989 Mar; 64(3):212-7. PubMed ID: 2566213
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic abnormalities in amyotrophic lateral sclerosis].
Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):195-8. PubMed ID: 3157286
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia classic commentary: 'Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology' by J. Overgaard, D. Gonzalez Gonzalez, M.C.C.H. Hulshof, G. Arcangeli, O. Dahl, O. Mella & S.M. Bentzen, International Journal of Hyperthermia 1996;12:3-20.
van der Zee J; Overgaard J
Int J Hyperthermia; 2009 Aug; 25(5):335-7. PubMed ID: 19670089
[No Abstract] [Full Text] [Related]
16. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.
Roszman TL; Brooks WH; Steele C; Elliott LH
J Immunol; 1985 Mar; 134(3):1545-50. PubMed ID: 3155771
[TBL] [Abstract][Full Text] [Related]
17. [Dynamics of the immune status and the role of the T-lymphocyte subpopulation in the acute period of craniocerebral injuries].
Gorbunov VI
Zh Vopr Neirokhir Im N N Burdenko; 1988; (3):28-31. PubMed ID: 2970750
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
19. [Hyperthermic therapy procedures for supplementing radiotherapy of malignant intraocular tumors].
Riedel KG
Klin Monbl Augenheilkd; 1988 Aug; 193(2):131-7. PubMed ID: 3054256
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
